China SXT shares rose about 186% to $3.58 per share. The story gives no company update, so this move alone does not change what we know about its business.
A share-price change alone does not show whether China SXT is selling more medicine, making more profit, or facing a new problem. The story gives no such company update, so it does not change what we know about its business.
Sunshine Biopharma shares rose about 151% to $1.00 per share. The story gives no company update, so this move alone does not change what we know about its business.
FF EAI Robotics Ecosystem shares rose about 33% to $1.84 per share. The story gives no company update, so this move alone does not change what we know about its business.
Apimeds Pharmaceuticals shares rose about 21% to $8.60 per share. The story gives no company update, so this move alone does not change what we know about its business.
Nautilus Biotechnology shares rose about 14% to $2.02 per share. The story gives no company update, so this move alone does not change what we know about its business.
Prime Medicine shares rose about 11% to $3.90 per share. The story gives no company update, so this move alone does not change what we know about its business.
Follow China SXT Pharmaceuticals (SXTC) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for SXTC